deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT02911298

Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules

An Open Label, Single-site Pharmaco-Scintigraphic Phase I - Study in Healthy Subjects to Evaluate the Gastrointestinal Transit and Release Profile of Radio-labelled Metronidazole Benzoate Capsules

Sponsor: SocraTec R&D GmbH

Conditions Healthy
Interventions Metronidazole Benzoate gastro-resistant capsule with radio-labelled mucoadhesive formulation Metronidazole Benzoate gastro-resistant capsule with radio-labelled non-mucoadhesive formulation
Updated 7 times since 2017 Last updated: Apr 3, 2017 Started: Nov 25, 2016 Primary completion: Mar 6, 2017 Completion: Mar 6, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02911298, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by SocraTec R&D GmbH, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~May 2017 · 3 months · monthly snapshotRecruiting~May 2017 – ~Jun 2018 · 13 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. May 2017 — Jun 2018 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

▶ Show 2 earlier versions

  1. Feb 2017 — May 2017 [monthly]

    Recruiting PHASE1

  2. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • SocraTec R&D GmbH
  • Swiss Commission for Technology and Innovation
  • Tillotts Pharma AG
  • University Hospital, Basel, Switzerland
  • University of Basel
Data source: Tillotts Pharma AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations